In part two of NJBIZ’s interview, BioNJ CEO Debbie Hart discusses policy, AI, manufacturing and what’s next for New Jersey life sciences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback